Matches in SemOpenAlex for { <https://semopenalex.org/work/W3046190112> ?p ?o ?g. }
- W3046190112 endingPage "1315" @default.
- W3046190112 startingPage "1302" @default.
- W3046190112 abstract "CHS-131 is a selective peroxisome proliferator-activated receptor gamma modulator with antidiabetic effects and less fluid retention and weight gain compared to thiazolidinediones in phase II clinical trials. We investigated the effects of CHS-131 on metabolic parameters and liver histopathology in a diet-induced obese (DIO) and biopsy-confirmed mouse model of nonalcoholic steatohepatitis (NASH). Male C57BL/6JRj mice were fed the amylin liver NASH diet (40% fat with trans-fat, 20% fructose, and 2% cholesterol). After 36 weeks, only animals with biopsy-confirmed steatosis and fibrosis were included and stratified into treatment groups (n = 12-13) to receive for the next 12 weeks (1) low-dose CHS-131 (10 mg/kg), (2) high-dose CHS-131 (30 mg/kg), or (3) vehicle. Metabolic parameters, liver pathology, metabolomics/lipidomics, markers of liver function and liver, and subcutaneous and visceral adipose tissue gene expression profiles were assessed. CHS-131 did not affect body weight, fat mass, lean mass, water mass, or food intake in DIO-NASH mice with fibrosis. CHS-131 improved fasting insulin levels and insulin sensitivity as assessed by the intraperitoneal insulin tolerance test. CHS-131 improved total plasma cholesterol, triglycerides, alanine aminotransferase, and aspartate aminotransferase and increased plasma adiponectin levels. CHS-131 (high dose) improved liver histology and markers of hepatic fibrosis. DIO-NASH mice treated with CHS-131 demonstrated a hepatic shift to diacylglycerols and triacylglycerols with a lower number of carbons, increased expression of genes stimulating fatty acid oxidation and browning, and decreased expression of genes promoting fatty acid synthesis, triglyceride synthesis, and inflammation in adipose tissue. Conclusion: CHS-131 improves liver histology in a DIO and biopsy-confirmed mouse model of NASH by altering the hepatic lipidome, reducing insulin resistance, and improving lipid metabolism and inflammation in adipose tissue." @default.
- W3046190112 created "2020-08-03" @default.
- W3046190112 creator A5005766189 @default.
- W3046190112 creator A5012608634 @default.
- W3046190112 creator A5022083596 @default.
- W3046190112 creator A5022992402 @default.
- W3046190112 creator A5026233541 @default.
- W3046190112 creator A5044243414 @default.
- W3046190112 creator A5050744085 @default.
- W3046190112 creator A5067265775 @default.
- W3046190112 creator A5069251431 @default.
- W3046190112 creator A5079439504 @default.
- W3046190112 date "2020-07-28" @default.
- W3046190112 modified "2023-10-16" @default.
- W3046190112 title "The Selective Peroxisome Proliferator‐Activated Receptor Gamma Modulator CHS‐131 Improves Liver Histopathology and Metabolism in a Mouse Model of Obesity and Nonalcoholic Steatohepatitis" @default.
- W3046190112 cites W131917179 @default.
- W3046190112 cites W1553157598 @default.
- W3046190112 cites W1866142084 @default.
- W3046190112 cites W1868475579 @default.
- W3046190112 cites W1975737070 @default.
- W3046190112 cites W1976439025 @default.
- W3046190112 cites W1977484873 @default.
- W3046190112 cites W2009332633 @default.
- W3046190112 cites W2061516414 @default.
- W3046190112 cites W2062812115 @default.
- W3046190112 cites W2067740038 @default.
- W3046190112 cites W2071030431 @default.
- W3046190112 cites W2085135498 @default.
- W3046190112 cites W2161727276 @default.
- W3046190112 cites W2172203327 @default.
- W3046190112 cites W2210672989 @default.
- W3046190112 cites W2320602240 @default.
- W3046190112 cites W2469365710 @default.
- W3046190112 cites W2470709274 @default.
- W3046190112 cites W2521120605 @default.
- W3046190112 cites W2523108177 @default.
- W3046190112 cites W2570564688 @default.
- W3046190112 cites W2618503376 @default.
- W3046190112 cites W2621939592 @default.
- W3046190112 cites W2734724639 @default.
- W3046190112 cites W2752428556 @default.
- W3046190112 cites W2753603256 @default.
- W3046190112 cites W2766539464 @default.
- W3046190112 cites W2775026689 @default.
- W3046190112 cites W2783806692 @default.
- W3046190112 cites W2789752648 @default.
- W3046190112 cites W2792659208 @default.
- W3046190112 cites W2793435344 @default.
- W3046190112 cites W2807586373 @default.
- W3046190112 cites W2809895957 @default.
- W3046190112 cites W2889932786 @default.
- W3046190112 cites W2901515479 @default.
- W3046190112 cites W2904806538 @default.
- W3046190112 cites W2944300826 @default.
- W3046190112 cites W2952983060 @default.
- W3046190112 cites W2955615964 @default.
- W3046190112 cites W2977825202 @default.
- W3046190112 cites W2982554056 @default.
- W3046190112 cites W2986955068 @default.
- W3046190112 cites W2998624963 @default.
- W3046190112 cites W3009902673 @default.
- W3046190112 cites W3020979243 @default.
- W3046190112 doi "https://doi.org/10.1002/hep4.1558" @default.
- W3046190112 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/7471426" @default.
- W3046190112 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/32923834" @default.
- W3046190112 hasPublicationYear "2020" @default.
- W3046190112 type Work @default.
- W3046190112 sameAs 3046190112 @default.
- W3046190112 citedByCount "12" @default.
- W3046190112 countsByYear W30461901122021 @default.
- W3046190112 countsByYear W30461901122022 @default.
- W3046190112 countsByYear W30461901122023 @default.
- W3046190112 crossrefType "journal-article" @default.
- W3046190112 hasAuthorship W3046190112A5005766189 @default.
- W3046190112 hasAuthorship W3046190112A5012608634 @default.
- W3046190112 hasAuthorship W3046190112A5022083596 @default.
- W3046190112 hasAuthorship W3046190112A5022992402 @default.
- W3046190112 hasAuthorship W3046190112A5026233541 @default.
- W3046190112 hasAuthorship W3046190112A5044243414 @default.
- W3046190112 hasAuthorship W3046190112A5050744085 @default.
- W3046190112 hasAuthorship W3046190112A5067265775 @default.
- W3046190112 hasAuthorship W3046190112A5069251431 @default.
- W3046190112 hasAuthorship W3046190112A5079439504 @default.
- W3046190112 hasBestOaLocation W30461901121 @default.
- W3046190112 hasConcept C126322002 @default.
- W3046190112 hasConcept C134018914 @default.
- W3046190112 hasConcept C170493617 @default.
- W3046190112 hasConcept C187345961 @default.
- W3046190112 hasConcept C2775934546 @default.
- W3046190112 hasConcept C2776175330 @default.
- W3046190112 hasConcept C2776782570 @default.
- W3046190112 hasConcept C2776954865 @default.
- W3046190112 hasConcept C2777391703 @default.
- W3046190112 hasConcept C2777766500 @default.
- W3046190112 hasConcept C2778772119 @default.
- W3046190112 hasConcept C2779134260 @default.
- W3046190112 hasConcept C2779306644 @default.
- W3046190112 hasConcept C2779478299 @default.